Drug-Induced Partial Immunosuppression for Preclinical Human Tumor Xenograft Models

This drug-induced partial immunosuppression protocol effectively creates a reproducible state of transient immunodeficiency in outbred mice, suitable for various human tumor xenograft models. It represents a cost-effective and flexible alternative to genetic models, with the distinct advantage of preserving a residual immune microenvironment, making it particularly valuable for preclinical studies that require a partially intact host immune system.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2025-12-17
DOI
https://doi.org/10.3390/cancers17244025
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-Induced Partial Immunosuppression for Preclinical Human Tumor Xenograft Models

E. A. Pryakhin, Dmitry B. Veprintsev, Vladimir A. Richter, Maxim V. Berezovski et al.
Cancers
Cancer Research and Treatments
article

Drug-Induced Partial Immunosuppression for Preclinical Human Tumor Xenograft Models

E. A. Pryakhin, Dmitry B. Veprintsev, Vladimir A. Richter, Maxim V. Berezovski, Natalia A. Luzan, Olga S. Kolovskaya, Vadim Kumeiko, Anastasia A. Koshmanova, Kirill A. Lukyanenko, E.V. Styazhkina, Elvira. S. Melikhova, Daniil S. Grek, А. А. Народов, T.A. Garkusha, Vladislav M. Farniev, М. А. Дымова, Evgeny V. Morozov, Anna S. Kichkailo, Elena V. Kuligina, Tatiana N. Zamay, Ivan I. Voronkovskii, Anton K. Gorbushin, Ekaterina A. Lipetskaya, Victoriya D. Kakhanova
article en

Abstract

This drug-induced partial immunosuppression protocol effectively creates a reproducible state of transient immunodeficiency in outbred mice, suitable for various human tumor xenograft models. It represents a cost-effective and flexible alternative to genetic models, with the distinct advantage of preserving a residual immune microenvironment, making it particularly valuable for preclinical studies that require a partially intact host immune system.

CancersVol. 17(24)
University of Ottawa (CA), Far Eastern Federal University (RU), Institute of Chemistry and Chemical Technology (RU), Krasnoyarsk State Medical University (RU), Institute of Chemical Biology and Fundamental Medicine (RU), Krasnoyarsk Regional Clinical Hospital (RU), Siberian Branch of the Russian Academy of Sciences (RU), A.V. Zhirmunsky National Scientific Center of Marine Biology Far Eastern Branch of the Russian Academy of Sciences (RU), Urals Research Center for Radiation Medicine (RU)
Openalex Percentile: Top 58%
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.